Russia to meet its Sputnik V vaccine export promises over next 6-9 months - RDIF chief
Dmitriev, head of the Russian Direct Investment Fund (RDIF), which is responsible for marketing the vaccine abroad, said 95% of the many multi-million-dose export deals the fund had signed would be supplied by manufacturers located outside of Russia
The calculations were based on preliminary data obtained 42 days after the first dose, Russia's health ministry, the state-run Gamaleya research centre and the Russian Direct Investment Fund (RDIF) said in a statement. Photo: Reuters
Major export deals to supply doses of the Sputnik V vaccine against Covid-19 will be fulfilled over the next six to nine months, the head of Russia's sovereign wealth fund, Kirill Dmitriev, told a Reuters Next summit on Thursday.
Dmitriev, head of the Russian Direct Investment Fund (RDIF), which is responsible for marketing the vaccine abroad, said 95% of the many multi-million-dose export deals the fund had signed would be supplied by manufacturers located outside of Russia.
